Hyperhomocysteine, methylenetetrahydrofolate reductase gene, and other risk factors in ischemic stroke

To investigate the relation between plasma homocysteine (Hcy) and cerebral ischemic diseases and that between polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and cerebral ischemic diseases. The plasma homocysteine (Hcy) and genetic polymorphism of MTHFR among forty-nine cases with i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Zhong hua yi xue za zhi 2002-01, Vol.82 (2), p.119-122
Hauptverfasser: Huang, Yining, Zhao Yl, Yu lan, Li, Shunwei
Format: Artikel
Sprache:chi
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 122
container_issue 2
container_start_page 119
container_title Zhong hua yi xue za zhi
container_volume 82
creator Huang, Yining
Zhao Yl, Yu lan
Li, Shunwei
description To investigate the relation between plasma homocysteine (Hcy) and cerebral ischemic diseases and that between polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and cerebral ischemic diseases. The plasma homocysteine (Hcy) and genetic polymorphism of MTHFR among forty-nine cases with ischemic cerebral diseases, including 25 with acute cerebral infarction (CI) and 25 with transient ischemic attacks (TIA), were investigated. Fifty-five age- and sex-matched healthy persons were used as controls. All the subjects underwent brain CT, carotid duplex, transcranial Doppler examination, plasma Vitamin B(12) and folic acid examination, besides examination of plasma Hcy and nucleotide 677 MTHFR genotypes. The effects of age, liver function, renal function, smoking, drinking, plasma vitamin B(12), and folic acid were analyzed. The mean plasma Hcy was significantly higher in the CI group and TIA group (17.4 +/- 7.6 micromol/L and 16.6 +/- 5.2 micromol/L) compared with that in the control group (12.6 +/- 5.2
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71603507</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71603507</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-184c3adb196c7c14c7386c2b12fc97e1c063e360dc34a6ebada5d18fb410c1fd3</originalsourceid><addsrcrecordid>eNo10DFPwzAUBGAPIFpB_wLyxEQkP9u1mxFVQJEqscAcOfYzsZrEwXaG_HuKKNMtn06nuyJrJrSquKxhRTY5h5ZJLWrOONyQFUC9FSD5mvjDMmHq4hDtkguGER_pgKVbehyxYEmmW1yKPvamIE3oZltMRvqFv9KMjsbSYaIp5BP1xpaYMg0jDdl2OARLc0nxhHfk2ps-4-aSt-Tz5fljf6iO769v-6djNQHnpYKdtMK4FmpltQVptdgpy1vg3tYawTIlUCjmrJBGYWuc2TrY-VYCs-CduCUPf71Tit8z5tIM5yXY92bEOOdGg2Jiy_QZ3l_g3A7omimFwaSl-X9G_ACBoGJO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71603507</pqid></control><display><type>article</type><title>Hyperhomocysteine, methylenetetrahydrofolate reductase gene, and other risk factors in ischemic stroke</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Huang, Yining ; Zhao Yl, Yu lan ; Li, Shunwei</creator><creatorcontrib>Huang, Yining ; Zhao Yl, Yu lan ; Li, Shunwei</creatorcontrib><description>To investigate the relation between plasma homocysteine (Hcy) and cerebral ischemic diseases and that between polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and cerebral ischemic diseases. The plasma homocysteine (Hcy) and genetic polymorphism of MTHFR among forty-nine cases with ischemic cerebral diseases, including 25 with acute cerebral infarction (CI) and 25 with transient ischemic attacks (TIA), were investigated. Fifty-five age- and sex-matched healthy persons were used as controls. All the subjects underwent brain CT, carotid duplex, transcranial Doppler examination, plasma Vitamin B(12) and folic acid examination, besides examination of plasma Hcy and nucleotide 677 MTHFR genotypes. The effects of age, liver function, renal function, smoking, drinking, plasma vitamin B(12), and folic acid were analyzed. The mean plasma Hcy was significantly higher in the CI group and TIA group (17.4 +/- 7.6 micromol/L and 16.6 +/- 5.2 micromol/L) compared with that in the control group (12.6 +/- 5.2</description><identifier>ISSN: 0376-2491</identifier><identifier>PMID: 11953142</identifier><language>chi</language><publisher>China</publisher><subject>Asian Continental Ancestry Group - genetics ; Brain Ischemia - blood ; Brain Ischemia - diagnosis ; Brain Ischemia - enzymology ; Brain Ischemia - genetics ; Female ; Gene Frequency ; Genetic Predisposition to Disease ; Homocysteine - blood ; Humans ; Kidney Function Tests ; Male ; Methylenetetrahydrofolate Reductase (NADPH2) ; Middle Aged ; Mutation ; Oxidoreductases Acting on CH-NH Group Donors - genetics ; Prognosis ; Risk Factors ; Smoking - adverse effects ; Smoking - blood</subject><ispartof>Zhong hua yi xue za zhi, 2002-01, Vol.82 (2), p.119-122</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11953142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Yining</creatorcontrib><creatorcontrib>Zhao Yl, Yu lan</creatorcontrib><creatorcontrib>Li, Shunwei</creatorcontrib><title>Hyperhomocysteine, methylenetetrahydrofolate reductase gene, and other risk factors in ischemic stroke</title><title>Zhong hua yi xue za zhi</title><addtitle>Zhonghua Yi Xue Za Zhi</addtitle><description>To investigate the relation between plasma homocysteine (Hcy) and cerebral ischemic diseases and that between polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and cerebral ischemic diseases. The plasma homocysteine (Hcy) and genetic polymorphism of MTHFR among forty-nine cases with ischemic cerebral diseases, including 25 with acute cerebral infarction (CI) and 25 with transient ischemic attacks (TIA), were investigated. Fifty-five age- and sex-matched healthy persons were used as controls. All the subjects underwent brain CT, carotid duplex, transcranial Doppler examination, plasma Vitamin B(12) and folic acid examination, besides examination of plasma Hcy and nucleotide 677 MTHFR genotypes. The effects of age, liver function, renal function, smoking, drinking, plasma vitamin B(12), and folic acid were analyzed. The mean plasma Hcy was significantly higher in the CI group and TIA group (17.4 +/- 7.6 micromol/L and 16.6 +/- 5.2 micromol/L) compared with that in the control group (12.6 +/- 5.2</description><subject>Asian Continental Ancestry Group - genetics</subject><subject>Brain Ischemia - blood</subject><subject>Brain Ischemia - diagnosis</subject><subject>Brain Ischemia - enzymology</subject><subject>Brain Ischemia - genetics</subject><subject>Female</subject><subject>Gene Frequency</subject><subject>Genetic Predisposition to Disease</subject><subject>Homocysteine - blood</subject><subject>Humans</subject><subject>Kidney Function Tests</subject><subject>Male</subject><subject>Methylenetetrahydrofolate Reductase (NADPH2)</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Oxidoreductases Acting on CH-NH Group Donors - genetics</subject><subject>Prognosis</subject><subject>Risk Factors</subject><subject>Smoking - adverse effects</subject><subject>Smoking - blood</subject><issn>0376-2491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo10DFPwzAUBGAPIFpB_wLyxEQkP9u1mxFVQJEqscAcOfYzsZrEwXaG_HuKKNMtn06nuyJrJrSquKxhRTY5h5ZJLWrOONyQFUC9FSD5mvjDMmHq4hDtkguGER_pgKVbehyxYEmmW1yKPvamIE3oZltMRvqFv9KMjsbSYaIp5BP1xpaYMg0jDdl2OARLc0nxhHfk2ps-4-aSt-Tz5fljf6iO769v-6djNQHnpYKdtMK4FmpltQVptdgpy1vg3tYawTIlUCjmrJBGYWuc2TrY-VYCs-CduCUPf71Tit8z5tIM5yXY92bEOOdGg2Jiy_QZ3l_g3A7omimFwaSl-X9G_ACBoGJO</recordid><startdate>20020125</startdate><enddate>20020125</enddate><creator>Huang, Yining</creator><creator>Zhao Yl, Yu lan</creator><creator>Li, Shunwei</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20020125</creationdate><title>Hyperhomocysteine, methylenetetrahydrofolate reductase gene, and other risk factors in ischemic stroke</title><author>Huang, Yining ; Zhao Yl, Yu lan ; Li, Shunwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-184c3adb196c7c14c7386c2b12fc97e1c063e360dc34a6ebada5d18fb410c1fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2002</creationdate><topic>Asian Continental Ancestry Group - genetics</topic><topic>Brain Ischemia - blood</topic><topic>Brain Ischemia - diagnosis</topic><topic>Brain Ischemia - enzymology</topic><topic>Brain Ischemia - genetics</topic><topic>Female</topic><topic>Gene Frequency</topic><topic>Genetic Predisposition to Disease</topic><topic>Homocysteine - blood</topic><topic>Humans</topic><topic>Kidney Function Tests</topic><topic>Male</topic><topic>Methylenetetrahydrofolate Reductase (NADPH2)</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Oxidoreductases Acting on CH-NH Group Donors - genetics</topic><topic>Prognosis</topic><topic>Risk Factors</topic><topic>Smoking - adverse effects</topic><topic>Smoking - blood</topic><toplevel>online_resources</toplevel><creatorcontrib>Huang, Yining</creatorcontrib><creatorcontrib>Zhao Yl, Yu lan</creatorcontrib><creatorcontrib>Li, Shunwei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Zhong hua yi xue za zhi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Yining</au><au>Zhao Yl, Yu lan</au><au>Li, Shunwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperhomocysteine, methylenetetrahydrofolate reductase gene, and other risk factors in ischemic stroke</atitle><jtitle>Zhong hua yi xue za zhi</jtitle><addtitle>Zhonghua Yi Xue Za Zhi</addtitle><date>2002-01-25</date><risdate>2002</risdate><volume>82</volume><issue>2</issue><spage>119</spage><epage>122</epage><pages>119-122</pages><issn>0376-2491</issn><abstract>To investigate the relation between plasma homocysteine (Hcy) and cerebral ischemic diseases and that between polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and cerebral ischemic diseases. The plasma homocysteine (Hcy) and genetic polymorphism of MTHFR among forty-nine cases with ischemic cerebral diseases, including 25 with acute cerebral infarction (CI) and 25 with transient ischemic attacks (TIA), were investigated. Fifty-five age- and sex-matched healthy persons were used as controls. All the subjects underwent brain CT, carotid duplex, transcranial Doppler examination, plasma Vitamin B(12) and folic acid examination, besides examination of plasma Hcy and nucleotide 677 MTHFR genotypes. The effects of age, liver function, renal function, smoking, drinking, plasma vitamin B(12), and folic acid were analyzed. The mean plasma Hcy was significantly higher in the CI group and TIA group (17.4 +/- 7.6 micromol/L and 16.6 +/- 5.2 micromol/L) compared with that in the control group (12.6 +/- 5.2</abstract><cop>China</cop><pmid>11953142</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0376-2491
ispartof Zhong hua yi xue za zhi, 2002-01, Vol.82 (2), p.119-122
issn 0376-2491
language chi
recordid cdi_proquest_miscellaneous_71603507
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Asian Continental Ancestry Group - genetics
Brain Ischemia - blood
Brain Ischemia - diagnosis
Brain Ischemia - enzymology
Brain Ischemia - genetics
Female
Gene Frequency
Genetic Predisposition to Disease
Homocysteine - blood
Humans
Kidney Function Tests
Male
Methylenetetrahydrofolate Reductase (NADPH2)
Middle Aged
Mutation
Oxidoreductases Acting on CH-NH Group Donors - genetics
Prognosis
Risk Factors
Smoking - adverse effects
Smoking - blood
title Hyperhomocysteine, methylenetetrahydrofolate reductase gene, and other risk factors in ischemic stroke
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A14%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperhomocysteine,%20methylenetetrahydrofolate%20reductase%20gene,%20and%20other%20risk%20factors%20in%20ischemic%20stroke&rft.jtitle=Zhong%20hua%20yi%20xue%20za%20zhi&rft.au=Huang,%20Yining&rft.date=2002-01-25&rft.volume=82&rft.issue=2&rft.spage=119&rft.epage=122&rft.pages=119-122&rft.issn=0376-2491&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71603507%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71603507&rft_id=info:pmid/11953142&rfr_iscdi=true